Infectious disease tests are one of the most dynamic spaces in the in vitro diagnostics (IVD) industry. Global market growth is a product of new disease threats as well as the introduction and clinical acceptance of routine screening procedures. The diversified market space promotes demand for novel diagnostic technologies such as PCR-alternative molecular amplification methods, next-generation sequencing (NGS), and mass spectrometry. The $17 billion+ global infectious disease diagnostics market also includes larger established segments in immunoassays and ID/AST.
In light of the COVID-19 (coronavirus) pandemic, it is extremely timely to present a report on the status quo in emerging infectious diseases. While the current pandemic is troublesome and has disrupted normal life, it will follow its course and then fade away. Where could the next pandemic or epidemic come from? There are a number […]
The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine […]
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing […]
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2019-2024 saves time with calculations and estimates of the both the existing number of procedures for […]
Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of […]
Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts. Test Segments: Market Sizing and Forecasts There are several […]
Molecular diagnostics is a fast evolving and dynamic field and is the fastest growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in […]
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential […]
An in-depth look at the global POC testing market yields several interesting facts that are explored in this report. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. Worldwide Market for Point-of-Care (POC) Diagnostics explores the main issues and trends affecting this market, influencing its move into the future. These include wearables, patient-centered healthcare, regulatory hurdles, and reimbursement challenges. Factors driving the development of POC tests are discussed as well, including patient-focused drivers, medical/healthcare-related drivers, technology drivers, and economic drivers.
Clinical laboratories are an essential part of the health industry. It is estimated that between 70% – 80% of physicians’ diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. Clinical Laboratory […]
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.